<DOC>
	<DOCNO>NCT02309372</DOCNO>
	<brief_summary>This trial determine depression treatment reduce cardiovascular risk HIV-infected patient already receive HIV treatment . Half participant undergo specific computerize depression treatment half receive usual care HIV provider .</brief_summary>
	<brief_title>Depression Therapy Improve Cardiovascular Risk HIV</brief_title>
	<detailed_description>The objective study meet perform 24-week , randomize , control , single-blinded , two-arm , parallel group , pilot trial single center . A total 200 subject may screen identify 110 participant enrol randomize . These participant ≥ 18 year old , receive antiretroviral therapy least one year HIV viral load &lt; 75 copies/mL screening , major depression use PHQ-9 questionnaire . These participant randomize 1:1 either depression treatment Beating-the-Blues cognitive behavioral therapy program ( N=55 ) usual care ( N=55 ) .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<criteria>HIV1 infection , document : ( 1 ) license rapid HIV test HIV enzyme test kit time prior study entry ( 2 ) least one detectable HIV1 antigen least one detectable plasma HIV1 RNA viral load Age equal great 18 year Receipt antiretroviral therapy kind least 360 day prior screen Note : Interruptions ART 14 day total 360 day prior screen allow HIV1 RNA level &lt; 75 copies/mL screen NOTE : There CD4 cell count eligibility criteria trial For woman still reproductive potential , negative urine pregnancy test Depression define score ≥ 10 PHQ9 questionnaire Inability complete write , informed consent Incarceration time study visit Active suicidality use PHQ9 question # 9 positive response 3 question use Patient Suicidality Form Diagnosed vascular disease ( documented history angina pectoris , coronary disease , peripheral vascular disease , cerebrovascular disease , aortic aneurysm , otherwise know atherosclerotic disease ) History congestive heart failure , even currently compensate Diagnosed disease process , besides HIV infection , associate increase systemic inflammation ( include , limited , systemic lupus erythematosis , inflammatory bowel disease , collagen vascular disease ) Note : Hepatitis B C coinfections NOT exclusionary Known suspect malignancy require systemic treatment within 180 day screen NOTE : Localized treatment skin cancer exclusionary History migraine headache History Raynaud 's phenomenon History cardiac arrhythmia cardiomyopathy Uncontrolled hyperthyroidism hypothyroidism , define TSH value outside local reference range recent clinical assessment History carotid bruit Systolic blood pressure &gt; 160 mmHg diastolic blood pressure &gt; 110 mmHg screen Screening creatinine clearance &lt; 60 mL/min/1.732 ( use 2009 CKDEPI equation ) use serum creatinine level measure screen Screening glucose ≥ 140 mg/dL hemoglobin A1c &gt; 8.0 % Screening total cholesterol &gt; 240 mg/dL Therapy serious medical illness within 14 day prior screen Note : Therapy serious medical illness overlap main study visit result postponement study visit course therapy complete ; postponement outside allow study visit timeframe result study discontinuation Pregnancy breastfeed course study Receipt investigational agent , cytotoxic chemotherapy , systemic glucocorticoid ( dose ) , anabolic steroid screen Note : Physiologic testosterone replacement therapy topical steroid exclusionary . Inhaled/nasal steroid exclusionary long participant also receive HIV protease inhibitor Active drug use dependence , opinion investigator , would interfere adherence study requirement History schizophrenia bipolar disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>